Development, Molecular Docking, and <i>In Silico</i> ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications <i>via</i> Suppression of the Polyol Pathway-Reference-Cited by-同舟云学术

Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway

Published:2022-07-19 Issue:30 Volume:7 Page:26425-26436
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Imran Aqeel¹²³,Shehzad Muhammad Tariq⁴,Shah Syed Jawad Ali¹,Laws Mark³,al-Adhami Taha³,Rahman Khondaker Miraz³^ORCID,Khan Imtiaz Ali⁵,Shafiq Zahid⁴⁶,Iqbal Jamshed¹²^ORCID

Affiliation:

1. Center for Advanced Drug Research, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan

2. Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan

3. Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom

4. Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan

5. Department of Entomology, University of Agriculture, Peshawar 25130, Khyber Pakhtunkhwa, Pakistan

6. Pharmaceutical Institute, Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany

Funder

Higher Education Commission, Pakistan

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c02326

Reference37 articles.